Tremtelectogene Empogeditemcel

Approval Year

Substance Class	Structurally Diverse Created by `admin` on `Sat Dec 16 18:45:59 GMT 2023` Edited by `admin` on `Sat Dec 16 18:45:59 GMT 2023`
Source Materials Class	ORGANISM
Source Materials Type	ALLOGENIC HUMAN
Source Materials Parent	`G0T704E6Z3` HOMO SAPIENS WHOLE
Part	BLOOD
Fraction Name	CD34+ enriched Hematopoietic Stem/Progenitor Cell from HLA matched donor
Record UNII	CT5FM8JN3S
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Tremtelectogene Empogeditemcel

Code

English

allogeneic human CD34 + hematopoietic stem and progenitor cells (HSPC) obtained from peripheral blood by leukapheresis from human leukocyte antigen (HLA)-matched healthy donors, genetically modified ex vivo by CRISPR/Cas9 (clustered regularly interspaced

Common Name

English

tremtelectogene empogeditemcel [INN]

Common Name

English

Code System Code Type Description

INN

12263

Created by admin on Sat Dec 16 18:45:59 GMT 2023 , Edited by admin on Sat Dec 16 18:45:59 GMT 2023

PRIMARY

FDA UNII

CT5FM8JN3S

Created by admin on Sat Dec 16 18:45:59 GMT 2023 , Edited by admin on Sat Dec 16 18:45:59 GMT 2023

PRIMARY

NCI_THESAURUS

C180524

Created by admin on Sat Dec 16 18:45:59 GMT 2023 , Edited by admin on Sat Dec 16 18:45:59 GMT 2023

PRIMARY

Related Record Type Details


					CT5FM8JN3S

Tremtelectogene Empogeditemcel

ACTIVE MOIETY

Comments:

VOR33 will be infused into patients with acute myeloid leukemia (AML) undergoing hematopoietic cell transplant who are known to be at high-risk for leukemia relapse and mortality post transplantation.

Amount: